Search jobs Abbott's New Coronary Imaging Platform Powered By Artificial Intelligence Launches in Europe - New imaging platform merges optical coherence tomography (OCT) with the power of automation using artificial intelligence (AI) - Ultreon 1.0 Software helps physicians automatically detect and quantify blood vessel characteristics, giving them better insights for optimal patient treatment - Platform offers advanced imaging features when combined with the Dragonfly OpStar™ imaging catheter used to access complex anatomy ABBOTT PARK, Ill., April 26, 2021 — Abbott today announced that its new imaging platform powered by Ultreon 1.0 Software, is now CE Marked in Europe. This first-of-its-kind imaging software merges optical coherence tomography (OCT) – an imaging tool that provides physicians a comprehensive view inside an artery or blood vessel – with the power of artificial intelligence (AI) for enhanced visualization. The new Ultreon Software can automatically detect the severity of calcium-based blockages and measure vessel diameter to enhance the precision of physicians’ decision-making during coronary stenting procedures.